These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28719264)

  • 1. The Human Microbiome in the Fight Against Tuberculosis.
    Wood MR; Yu EA; Mehta S
    Am J Trop Med Hyg; 2017 Jun; 96(6):1274-1284. PubMed ID: 28719264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of model systems to study adaptive responses of Mycobacterium tuberculosis during infection and disease.
    Gordhan BG; Peters J; Kana BD
    Adv Appl Microbiol; 2019; 108():115-161. PubMed ID: 31495404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?
    Eribo OA; du Plessis N; Ozturk M; Guler R; Walzl G; Chegou NN
    Cell Mol Life Sci; 2020 Apr; 77(8):1497-1509. PubMed ID: 31729564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gut microbiome: A line of defense against tuberculosis development.
    Yu Z; Shen X; Wang A; Hu C; Chen J
    Front Cell Infect Microbiol; 2023; 13():1149679. PubMed ID: 37143744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The host microbiome and impact of tuberculosis chemotherapy.
    O'Toole RF; Gautam SS
    Tuberculosis (Edinb); 2018 Dec; 113():26-29. PubMed ID: 30514510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between Disease Severity and the Intestinal Microbiome in Mycobacterium tuberculosis-Infected Rhesus Macaques.
    Namasivayam S; Kauffman KD; McCulloch JA; Yuan W; Thovarai V; Mittereder LR; Trinchieri G; Barber DL; Sher A
    mBio; 2019 Jun; 10(3):. PubMed ID: 31164469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of microbiota in respiratory health and diseases, particularly in tuberculosis.
    Shah T; Shah Z; Baloch Z; Cui X
    Biomed Pharmacother; 2021 Nov; 143():112108. PubMed ID: 34560539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Microbiome and Tuberculosis: Early Evidence for Cross Talk.
    Namasivayam S; Sher A; Glickman MS; Wipperman MF
    mBio; 2018 Sep; 9(5):. PubMed ID: 30228238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis.
    Naidoo CC; Nyawo GR; Sulaiman I; Wu BG; Turner CT; Bu K; Palmer Z; Li Y; Reeve BWP; Moodley S; Jackson JG; Limberis J; Diacon AH; van Helden PD; Clemente JC; Warren RM; Noursadeghi M; Segal LN; Theron G
    EBioMedicine; 2021 May; 67():103374. PubMed ID: 33975252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human microbiota in pulmonary tuberculosis: Not so innocent bystanders.
    Tarashi S; Ahmadi Badi S; Moshiri A; Nasehi M; Fateh A; Vaziri F; Siadat SD
    Tuberculosis (Edinb); 2018 Dec; 113():215-221. PubMed ID: 30514505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiome diversity in the sputum of patients with pulmonary tuberculosis.
    Krishna P; Jain A; Bisen PS
    Eur J Clin Microbiol Infect Dis; 2016 Jul; 35(7):1205-10. PubMed ID: 27142586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis.
    Wipperman MF; Bhattarai SK; Vorkas CK; Maringati VS; Taur Y; Mathurin L; McAulay K; Vilbrun SC; Francois D; Bean J; Walsh KF; Nathan C; Fitzgerald DW; Glickman MS; Bucci V
    Nat Commun; 2021 Feb; 12(1):1141. PubMed ID: 33602926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microbiome and tuberculosis: state of the art, potential applications, and defining the clinical research agenda.
    Naidoo CC; Nyawo GR; Wu BG; Walzl G; Warren RM; Segal LN; Theron G
    Lancet Respir Med; 2019 Oct; 7(10):892-906. PubMed ID: 30910543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Sputum Microbiome in Pulmonary Tuberculosis and Its Association With Disease Manifestations: A Cross-Sectional Study.
    Ticlla MR; Hella J; Hiza H; Sasamalo M; Mhimbira F; Rutaihwa LK; Droz S; Schaller S; Reither K; Hilty M; Comas I; Beisel C; Schmid CD; Fenner L; Gagneux S
    Front Microbiol; 2021; 12():633396. PubMed ID: 34489876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gut microbiota mediates protective immunity against tuberculosis
    Yang F; Yang Y; Chen L; Zhang Z; Liu L; Zhang C; Mai Q; Chen Y; Chen Z; Lin T; Chen L; Guo H; Zhou L; Shen H; Chen X; Liu L; Zhang G; Liao H; Zeng L; Zeng G
    Gut Microbes; 2022; 14(1):2029997. PubMed ID: 35343370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel role of Yin-Yang-1 in pulmonary tuberculosis through the regulation of the chemokine CCL4.
    Rangel-Santiago JF; Baay-Guzman GJ; Duran-Padilla MA; Lopez-Bochm KA; Garcia-Romero BL; Hernandez-Cueto DD; Pantoja-Escobar G; Vega MI; Hernandez-Pando R; Huerta-Yepez S
    Tuberculosis (Edinb); 2016 Jan; 96():87-95. PubMed ID: 26786659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the gut-lung axis on tuberculosis susceptibility and progression.
    Enjeti A; Sathkumara HD; Kupz A
    Front Microbiol; 2023; 14():1209932. PubMed ID: 37485512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.